Stock market today: Live updates
Traders work on the floor of the New York Stock Exchange. NYSE Futures linked to the S&P 500…
Novartis CEO: Reality of Trump’s drug pricing to set in over next 18 months
Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult…
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
UK, China rush to forge business deals
China’s President Xi Jinping (R) and Britain’s Prime Minister Keir Starmer shake hands before their meeting at the…
AstraZeneca’s NYSE listing comes as it pours $15 billion into China
Pharma giant AstraZeneca will list on the New York Stock Exchange on Monday, days after it announced big…
Scientists Link Epstein-Barr Virus to Higher Risk of Lupus and Stroke
Scientists have identified 22 genes that increase the risk of conditions like lupus, stroke, and rheumatoid arthritis in…
Airbus, AstraZeneca and HSBC executives join UK’s Starmer on high-stakes China trip
British Prime Minister Keir Starmer at Downing Street on January 27, 2026 in London, England. Jack Taylor |…
Novo Nordisk, Pfizer execs weigh in
President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, Dec.…
Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…